Keppra - API Insight, 2019 - ResearchAndMarkets.com

The "Keppra - API Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Friday, January 25, 2019
Information
Tags: 
Health, Pharmaceutical, Drugs, Anticonvulsants, Levetiracetam, Racetams, Chemistry, Application programming interface, Web API
⚠generated by AI ↴
Summary
Key Points: 
  • The "Keppra - API Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • Keppra - API Insight, 2019 provides product and API manufacturers' details across the globe along with the location.
  • The report gives the clear idea on the country wise DMF filed by worldwide companies related to Keppra.
  • The report also highlights the patent details of Keppra.


The "Keppra
- API Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's
offering.

Keppra - API Insight, 2019 provides product and API
manufacturers' details across the globe along with the location. The
report gives the clear idea on the country wise DMF filed by worldwide
companies related to Keppra. The report also highlights the patent
details of Keppra.

Scope of the Report

  • A comprehensive product overview including product description,
    regulatory milestones, safety, pharmacological properties, clinical
    trials, and product development activities have been elaborated in
    this report
  • Patent information around Keppra in United States (US) and Europe (EU)
    has been highlighted
  • API manufacturers for Keppra in United States, Europe, China and India
  • The report contains historical and forecasted sales for Keppra till
    2021
  • Enlists the market competition and emerging therapies in the space
    where Keppra operates

Reasons to Buy

  • Evaluate the marketing status of Keppra to exploit opportunities for
    generic Keppra development opportunities
  • Design effective counter-strategies to gain competitive advantage by
    identifying the key patent expiry details with respect to Keppra
  • API intelligence over Keppra and gaining primary intelligence over
    Active Ingredient manufacturers by country
  • Make more informed business decisions from insightful and in-depth
    analysis of Keppra's performance

Topics Covered

1. Keppra Overview

2. Keppra Global Sales Assessment

  • Keppra Historical Global Sales
  • Keppra Forecasted Global Sales

3. Product Description

  • Mechanism of Action
  • Pharmacodynamic Properties
  • Pharmacokinetic Properties

4. Product Details by Country

5. Patent Information

6. Global API Manufacturers Assessment

  • Active Pharmaceutical Ingredient (API) Manufacturers by Country
  • Active Pharmaceutical Ingredient (API) Manufacturers by Region

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/45clgt/keppra_api?w=4

Copyright: 
Copyright Business Wire 2019